+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Opioids"

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
From
Opioid Use Disorder (OUD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Opioid Use Disorder (OUD) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 67 Pages
  • Global
From
From
From
ZYNRELEF Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZYNRELEF Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Maxigesic IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Maxigesic IV Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Europe, MEA Substance Abuse Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Europe, MEA Substance Abuse Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 73 Pages
  • Europe, Africa, Middle East Europe, Africa, Middle East
From
Gabapentin Market Report and Forecast 2025-2034 - Product Thumbnail Image

Gabapentin Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
Medical Cannabis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Medical Cannabis Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Burn Pain Market Report and Forecast 2025-2034 - Product Thumbnail Image

Burn Pain Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Postoperative Pain Management Pipeline Analysis Report 2025 - Product Thumbnail Image

Postoperative Pain Management Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Substance (Drug) Abuse Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Substance (Drug) Abuse Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Peripheral Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Opioid-induced Constipation Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Opioid-induced Constipation Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Postoperative Pain Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Postoperative Pain Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Acute Pain Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Acute Pain Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Acute Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Acute Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

Analgesics are a class of drugs used to relieve pain. Opioids are a type of analgesic that act on the nervous system to reduce the intensity of pain signals sent to the brain. Opioids are typically prescribed for moderate to severe pain, and are often used to treat chronic pain. They can be taken orally, injected, or applied topically. Opioids can be highly addictive and have a high potential for abuse, so they are typically prescribed with caution. Opioids are a major component of the analgesic market, and are used to treat a variety of conditions. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and codeine. Other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are also used to treat pain. Companies in the opioids market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more